tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

01 30 46 39 00

Leave a message, we'll get back to you





New tools to discover TIGIT/CD155 antagonists

We're pleased to introduce the new TIGIT /NFAT Reporter cell line (60538) and the corresponding CD155/TCR Activator Cell line (60548) by BPS Bioscience. Together, these two cell lines can be used to create a luciferase-based assay to identify antagonistic monoclonal antibodies targeting either TIGIT or its ligand CD155 (also known as PVR) in a cellular context.

We recommend also the neutralizing TIGIT antibody (71340) as a positive control.
 


 

Learn more on on Being bioreactive, tebu-bio's scientific blog:
"New TIGIT:CD155 cell-based assay to restore immune response"